Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Proximal Deep Vein Thrombosis(ODIXa-DVT)

Clinical trial NCT00839163 · COMPLETED

Trial details

NCT number: NCT00839163
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Venous Thrombosis Deep Vein Thrombosis

Start date: 2004-03-01
Primary completion: 2005-10-01
Enrollment: 613

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.